+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allergy Immunotherapy Market - Global Forecast 2026-2032- Product Image
Allergy Immunotherapy Market - Global Forecast 2026-2032- Product Image
New

Allergy Immunotherapy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 183 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4905050
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The allergy immunotherapy market is rapidly evolving with science-driven innovation, redefined care delivery models, and rising standards for durable patient results. Leaders in this space must act decisively to harness new opportunities and respond to complex supply chain, regulatory, and patient engagement demands.

Market Snapshot: Allergy Immunotherapy Market

The allergy immunotherapy market is moving through a stage of robust growth, expanding from a value of USD 2.04 billion in 2025 to USD 2.24 billion in 2026. It is set to achieve a compound annual growth rate (CAGR) of 10.36%, reaching USD 4.07 billion by 2032. This trajectory highlights an industry-wide redirection: traditional, short-term symptom management is giving way to approaches that focus on long-term modification of allergic disease. Increasingly, therapy developers are emphasizing protocols that both reduce medication dependency and improve quality of life across multiple allergy-related disorders.

Scope & Segmentation

  • Treatment Modalities: Epicutaneous, oral, subcutaneous, and sublingual immunotherapies support differentiated treatment strategies suitable for distinct patient demographics and clinical needs.
  • Allergen Types: Solutions are targeted for animal dander, dust mites, and food allergens such as egg, milk, peanut, and tree nut, as well as pollen, reflecting diverse development, safety, and compliance landscapes.
  • Delivery Formats: Dermal patches, drops, injections, and tablets are developed to maximize ease of use and patient adherence, which are critical for successful long-term therapy.
  • Technology Platforms: Utilization of adjuvant technologies, recombinant allergen techniques, and nanotechnology-based systems is aligned with the pursuit of immune system modulation and predictable patient responses.
  • Clinical Indications: The market covers allergic asthma, allergic rhinitis, atopic dermatitis, and urticaria, each necessitating tailored clinical and commercial approaches.
  • End Users: Homecare, hospitals, research and academic labs, and specialty clinics function as main care settings, influencing access and patient engagement along the care pathway.
  • Distribution Channels: Hospital pharmacy, online pharmacy, and retail pharmacy address various regional regulatory and logistical requirements, providing multiple avenues to serve patient needs.
  • Geographies: This market includes the Americas, Europe, Middle East & Africa, and Asia-Pacific. Each region is shaped by distinct payer systems, regulatory frameworks, and operational challenges that require carefully adapted strategies.

Key Takeaways

  • Clinical practice is prioritizing disease modification for allergic conditions, extending focus beyond immediate symptom relief and paving the way for improved long-term patient management.
  • Advanced nanotechnology and recombinant allergen solutions are unlocking precision therapies, supporting more reliable patient outcomes and adherence.
  • Decentralized and home-based treatment formats, including sublingual tablets and epicutaneous patches, are expanding patient access and changing the delivery paradigm.
  • Manufacturers are adapting to evolving global supply chain variables, with increased scrutiny on sourcing, pricing flexibility, and the resilience of production networks.
  • Payers and healthcare providers now emphasize evidence from real-world data and post-market monitoring, reflecting greater demand for value-based proof in therapy adoption.
  • Collaborative commercial strategies increasingly integrate digital support and service partnerships, enhancing the overall care model beyond the therapeutic agent.

Tariff Impact on Allergy Immunotherapy Value Chain

Shifts in pharmaceutical tariffs directly influence the allergy immunotherapy value chain, from ingredient sourcing to device sourcing and diagnostics. Increased import duties require agile operational planning, including strategic sourcing, strong inventory management, and flexible supplier agreements. These changes can affect clinical timelines and distribution logistics, compelling manufacturers to provide more transparency in pricing and adapt to varying cost pressures across markets. As payers continue to monitor cost-effectiveness, supply chain resilience and responsive pricing models become essential for sustained access.

Methodology & Data Sources

This research uses structured interviews with industry specialists, comprehensive literature analysis, and detailed review of regulatory and technical filings. Triangulation across clinical trial registries and product documentation, alongside scenario-based stress testing of tariffs and supply issues, enhances the credibility and strategic depth of guidance offered.

Why This Report Matters

  • Enables executives to reinforce supply chain management, accelerate technology adoption, and build effective geographic strategies in allergy immunotherapy portfolios.
  • Informs evidence-based decision-making on segmentation, product differentiation, and changing payer dynamics, supporting both operational efficiency and commercial value creation.
  • Guides targeted investment based on robust analysis of emerging competitive drivers and technological trends shaping tomorrow’s market landscape.

Conclusion

The allergy immunotherapy industry continues its upward growth as clinical, operational, and commercial priorities converge. Organizations leveraging these insights are positioned to lead market transformation and foster durable improvements in patient care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Allergy Immunotherapy Market, by Allergy Type
8.1. Allergic Asthma
8.2. Allergic Rhinitis
8.3. Atopic Dermatitis
8.4. Urticaria
9. Allergy Immunotherapy Market, by Allergen Type
9.1. Animal Dander
9.1.1. Cat Allergens
9.1.2. Dog Allergens
9.2. Dust Mites
9.3. Food Allergens
9.3.1. Egg Allergens
9.3.2. Milk Allergens
9.3.3. Peanut Allergens
9.3.4. Tree Nut Allergens
9.4. Pollen
10. Allergy Immunotherapy Market, by Treatment Type
10.1. Epicutaneous Immunotherapy
10.2. Oral Immunotherapy
10.3. Subcutaneous Immunotherapy
10.4. Sublingual Immunotherapy
11. Allergy Immunotherapy Market, by Immunotherapy Delivery Form
11.1. Dermal Patch
11.2. Drops
11.3. Injections
11.4. Tablets
12. Allergy Immunotherapy Market, by Technology Platform
12.1. Adjuvants
12.2. Nanotechnology-Based Platforms
12.3. Recombinant Allergens
13. Allergy Immunotherapy Market, by End User
13.1. Homecare Settings
13.2. Hospitals
13.3. Research & Academic Laboratories
13.4. Specialty Clinics
14. Allergy Immunotherapy Market, by Distribution Channel
14.1. Hospital Pharmacy
14.2. Online Pharmacy
14.3. Retail Pharmacy
15. Allergy Immunotherapy Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Allergy Immunotherapy Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Allergy Immunotherapy Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Allergy Immunotherapy Market
19. China Allergy Immunotherapy Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. Adamis Pharmaceuticals Corporation
20.6. Aimmune Therapeutics Inc.
20.7. ALK-Abelló A/S
20.8. Allergopharma GmbH & Co. KG
20.9. Allergy Therapeutics plc
20.10. Allovate LLC
20.11. Anergis SA
20.12. ASIT Biotech SA
20.13. Biomay AG
20.14. Circassia Pharmaceuticals Inc.
20.15. DBV Technologies SA
20.16. Desentum Oy
20.17. HAL Allergy B.V.
20.18. HollisterStier Allergy Inc.
20.19. Inmunotek S.L.
20.20. Jubilant HollisterStier LLC
20.21. LETI Pharma S.L.
20.22. Leti-allergoid
20.23. Merck KGaA
20.24. Mylan N.V.
20.25. Novartis AG
20.26. Stallergenes Greer International AG
20.27. Thermo Fisher Scientific Inc.
20.28. Torii Pharmaceutical Co., Ltd.
20.29. WOLW Pharma Limited
List of Figures
FIGURE 1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC ASTHMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC ASTHMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC ASTHMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ATOPIC DERMATITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ATOPIC DERMATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY URTICARIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY URTICARIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY URTICARIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY CAT ALLERGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY CAT ALLERGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY CAT ALLERGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DOG ALLERGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DOG ALLERGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DOG ALLERGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DUST MITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DUST MITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DUST MITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EGG ALLERGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EGG ALLERGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EGG ALLERGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY MILK ALLERGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY MILK ALLERGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY MILK ALLERGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY PEANUT ALLERGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY PEANUT ALLERGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY PEANUT ALLERGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREE NUT ALLERGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREE NUT ALLERGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREE NUT ALLERGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY POLLEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY POLLEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY POLLEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EPICUTANEOUS IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EPICUTANEOUS IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EPICUTANEOUS IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ORAL IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ORAL IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ORAL IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DERMAL PATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DERMAL PATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DERMAL PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DROPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DROPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DROPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ADJUVANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ADJUVANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ADJUVANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY NANOTECHNOLOGY-BASED PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY NANOTECHNOLOGY-BASED PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY NANOTECHNOLOGY-BASED PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RECOMBINANT ALLERGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RECOMBINANT ALLERGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RECOMBINANT ALLERGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. EUROPE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. EUROPE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 152. EUROPE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 153. EUROPE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 154. EUROPE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 155. EUROPE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 156. EUROPE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. EUROPE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 170. AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 171. AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 172. AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 173. AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 174. AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 175. AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 176. AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. ASEAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. ASEAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASEAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 192. ASEAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 193. ASEAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 194. ASEAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 195. ASEAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 196. ASEAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 197. ASEAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. ASEAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 199. GCC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. GCC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 201. GCC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 202. GCC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 203. GCC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 204. GCC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 205. GCC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 206. GCC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 207. GCC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. GCC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 219. BRICS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. BRICS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 221. BRICS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 222. BRICS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 223. BRICS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 224. BRICS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 225. BRICS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 226. BRICS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 227. BRICS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 228. BRICS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. G7 ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. G7 ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 231. G7 ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 232. G7 ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 233. G7 ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 234. G7 ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 235. G7 ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 236. G7 ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 237. G7 ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. G7 ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 239. NATO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. NATO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 241. NATO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 242. NATO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 243. NATO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 244. NATO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 245. NATO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 246. NATO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 247. NATO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. NATO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 260. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 261. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2032 (USD MILLION)
TABLE 262. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
TABLE 263. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2032 (USD MILLION)
TABLE 264. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2032 (USD MILLION)
TABLE 265. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 266. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2032 (USD MILLION)
TABLE 267. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 268. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 269. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Allergy Immunotherapy market report include:
  • Adamis Pharmaceuticals Corporation
  • Aimmune Therapeutics Inc.
  • ALK-Abelló A/S
  • Allergopharma GmbH & Co. KG
  • Allergy Therapeutics plc
  • Allovate LLC
  • Anergis SA
  • ASIT Biotech SA
  • Biomay AG
  • Circassia Pharmaceuticals Inc.
  • DBV Technologies SA
  • Desentum Oy
  • HAL Allergy B.V.
  • HollisterStier Allergy Inc.
  • Inmunotek S.L.
  • Jubilant HollisterStier LLC
  • LETI Pharma S.L.
  • Leti-allergoid
  • Merck KGaA
  • Mylan N.V.
  • Novartis AG
  • Stallergenes Greer International AG
  • Thermo Fisher Scientific Inc.
  • Torii Pharmaceutical Co., Ltd.
  • WOLW Pharma Limited

Table Information

Report AttributeDetails
No. of Pages183
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.24 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.07 Billion
Compound Annual Growth Rate10.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Allergy Immunotherapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

Allergy Immunotherapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 184 Pages
  • Global
From
Allergy Shots Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Allergy Shots Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 210 Pages
  • Global
From
Allergy Shots Market - Global Strategic Business Report - Product Image

Allergy Shots Market - Global Strategic Business Report

  • Report
  • 584 Pages
  • Global
From
Allergy Immunotherapies Market Size, Share, Trends and Forecast by Treatment Type, Allergy Type, Distribution Channel, and Region, 2025-2033 - Product Image

Allergy Immunotherapies Market Size, Share, Trends and Forecast by Treatment Type, Allergy Type, Distribution Channel, and Region, 2025-2033

  • Report
  • 141 Pages
  • Global
From
Food Allergy Immunotherapy Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Food Allergy Immunotherapy Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Allergy Immunotherapy Market

Allergy Immunotherapy is a form of treatment for allergies that involves administering small doses of allergens to the patient over a period of time. This helps the patient build up a tolerance to the allergens, reducing the severity of their allergic reactions. Allergy Immunotherapy is often used in conjunction with other forms of allergy treatment, such as antihistamines and decongestants. Allergy Immunotherapy is a growing market, with a variety of products available to treat different types of allergies. These products range from sublingual drops and tablets to injections and nasal sprays. Many of these products are available over the counter, while others require a prescription from a doctor. The Allergy Immunotherapy market is highly competitive, with many companies offering products to treat different types of allergies. Some of the major players in the market include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, and Circassia. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.